药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dolasetron
Pipamperone
The risk or severity of adverse effects can be increased when Nifedipine is combined with Pipamperone.
Dolasetron
Nitrous acid
The risk or severity of adverse effects can be increased when Nifedipine is combined with Nitrous acid.
Dolasetron
Dinutuximab
The risk or severity of adverse effects can be increased when Nifedipine is combined with Dinutuximab.
Dolasetron
Obinutuzumab
The risk or severity of adverse effects can be increased when Nifedipine is combined with Obinutuzumab.
Dolasetron
Nesiritide
The risk or severity of adverse effects can be increased when Nifedipine is combined with Nesiritide.
Dolasetron
Carbetocin
The risk or severity of adverse effects can be increased when Nifedipine is combined with Carbetocin.
Dolasetron
Amifostine
The risk or severity of adverse effects can be increased when Nifedipine is combined with Amifostine.
Dolasetron
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nifedipine.
Dolasetron
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nifedipine.
Dolasetron
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Nifedipine.
Dolasetron
Rilpivirine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Nifedipine.
Dolasetron
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Nifedipine.
Dolasetron
Indacaterol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nifedipine.
Dolasetron
Posaconazole
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nifedipine.
Dolasetron
Chlorprothixene
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nifedipine.
Dolasetron
Ezogabine
The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Ezogabine.
Dolasetron
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nifedipine.
Dolasetron
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nifedipine.
Dolasetron
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Nifedipine.
Dolasetron
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Nifedipine.